Jyotivardhan Jaipuria on where to put money on the table and where to take it off

Valentis Advisors’ Jyotivardhan Jaipuria favors chemicals due to low dealer stocking and cement, anticipating benefits from consolidation and government demand. Pharma, particularly CDMO, shows growth potential, with US generics attractive on corrections. Small and mid-caps offer stronger earnings growth, but valuation is key. He remains cautious on alcobev due to fluctuating state policies.

Dalal Street Week Ahead: Nifty near breakout as resistance seen at 25,100; PSU banks, energy lead sectoral momentum

The Nifty showed signs of upward movement after a two-week consolidation, closing with a weekly gain of 1.02%. It faces resistance at 25,100-25,150, and a breakout is needed for a sustained uptrend. PSU Banks are expected to outperform, while IT shows bottoming-out signs. A cautiously positive approach is advised, focusing on profit protection and strong technical setups.